LENSAR INC (LNSR) Stock Price, Quote, News and Overview
NASDAQ:LNSR - Nasdaq - US52634L1089 - Common Stock - Currency: USD
LNSR Quote, Performance and Key Statistics
NASDAQ:LNSR (8/12/2025, 10:00:05 AM)
13.01
-0.02 (-0.15%)
The current stock price of LNSR is 13.01 USD. In the past month the price increased by 1.01%. In the past year, price increased by 198.17%.
LNSR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.74 | 227.94B | ||
| ISRG | INTUITIVE SURGICAL INC | 58.96 | 170.14B | ||
| BSX | BOSTON SCIENTIFIC CORP | 36.34 | 152.17B | ||
| SYK | STRYKER CORP | 29.38 | 144.27B | ||
| MDT | MEDTRONIC PLC | 16.89 | 118.99B | ||
| BDX | BECTON DICKINSON AND CO | 13.58 | 55.55B | ||
| IDXX | IDEXX LABORATORIES INC | 54.27 | 52.42B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30.23 | 45.58B | ||
| RMD | RESMED INC | 29.91 | 41.88B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.9 | 33.93B | ||
| DXCM | DEXCOM INC | 46.62 | 31.08B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.16 | 25.99B |
Related stock screener links
About LNSR
Company Profile
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 140 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The firm has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
Company Info
LENSAR INC
2800 Discovery Drive, Suite 100
Orlando FLORIDA 32826 US
CEO: Nicholas Curtis
Employees: 140
Phone: 18885367271
LENSAR INC / LNSR FAQ
What is the stock price of LENSAR INC today?
The current stock price of LNSR is 13.01 USD. The price decreased by -0.15% in the last trading session.
What is the ticker symbol for LENSAR INC stock?
The exchange symbol of LENSAR INC is LNSR and it is listed on the Nasdaq exchange.
On which exchange is LNSR stock listed?
LNSR stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for LENSAR INC stock?
7 analysts have analysed LNSR and the average price target is 15.3 USD. This implies a price increase of 17.6% is expected in the next year compared to the current price of 13.01. Check the LENSAR INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LENSAR INC worth?
LENSAR INC (LNSR) has a market capitalization of 153.39M USD. This makes LNSR a Micro Cap stock.
How many employees does LENSAR INC have?
LENSAR INC (LNSR) currently has 140 employees.
What are the support and resistance levels for LENSAR INC (LNSR) stock?
LENSAR INC (LNSR) has a support level at 13.03 and a resistance level at 13.17. Check the full technical report for a detailed analysis of LNSR support and resistance levels.
Is LENSAR INC (LNSR) expected to grow?
The Revenue of LENSAR INC (LNSR) is expected to grow by 31.82% in the next year. Check the estimates tab for more information on the LNSR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LENSAR INC (LNSR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LNSR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LNSR, evaluating the profitability, health, valuation and growth aspects
- LENSAR INC (LNSR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LENSAR INC (LNSR) Sales and EPS estimates to see what analysts future expectations are.
- LENSAR INC (LNSR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LENSAR INC (LNSR) Insider and Institutional Ownership to learn about the owners and their transactions.
- LENSAR INC (LNSR) Stock Chart to make your own analysis
- LENSAR INC (LNSR) Latest news and press-releases to stay up to date.
Does LENSAR INC (LNSR) stock pay dividends?
LNSR does not pay a dividend.
When does LENSAR INC (LNSR) report earnings?
LENSAR INC (LNSR) will report earnings on 2025-11-05, before the market open.
What is the Price/Earnings (PE) ratio of LENSAR INC (LNSR)?
LENSAR INC (LNSR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.85).
What is the Short Interest ratio of LENSAR INC (LNSR) stock?
The outstanding short interest for LENSAR INC (LNSR) is 5.34% of its float. Check the ownership tab for more information on the LNSR short interest.
LNSR Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to LNSR. When comparing the yearly performance of all stocks, LNSR is one of the better performing stocks in the market, outperforming 96.81% of all stocks.
LNSR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to LNSR. Both the profitability and financial health of LNSR have multiple concerns.
LNSR Financial Highlights
Over the last trailing twelve months LNSR reported a non-GAAP Earnings per Share(EPS) of -4.85. The EPS decreased by -206.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -77.57% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
LNSR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to LNSR. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 85.38% and a revenue growth 31.82% for LNSR